Head and neck melanoma

Cancer Control

Volumn 12, Issue 4, 2005, Pages 242-247

  Kienstra, Matthew A ^a   Padhya, Tapan A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER STAGING; HEAD; HEAD AND NECK MELANOMA; HUMAN; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MELANOMA; MORBIDITY; NECK; PLASTIC SURGERY; PROGNOSIS; QUALITY OF LIFE; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 27644586262     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480501200406     Document Type: Review

References (45)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Erratum in: CA Cancer J Clin. 2005;55:259.
3. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2002. Bethesda, Md: National Cancer Institute; 2004. Available at: http://seer.cancer.gOv/csr/1975_2002. Accessed September 6, 2005.
4. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma, II: sun exposure. Eur J Cancer. 2005;41:45-60.
5. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97:195-199.
6. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma, I: common and atypical naevi. Eur J Cancer. 2005;41: 28-44.
7. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and familial history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984;72:257-266.
8. Rigel DS. Epidemiology and prognostic factors in malignant melanoma. Ann Plast Surg. 1992;28:7-8.
9. Ballantyne AJ. Malignant melanoma of the skin of the head and neck: an analysis of 405 cases. Am J Surg. 1970;120:425-431.
10. Byers RM, Smith JL, Russell N, et al. Malignant melanoma of the external ear: review of 102 cases. Am J Surg. 1980;140:518-521.
11. Urist MM, Balch CM, Soong SJ, et al. Head and neck melanoma in 534 clinical stage I patients: a prognostic factors analysis and results of surgical treatment. Ann Surg. 1984;200:769-775.
12. Loree TR, Spiro RH. Cutaneous melanoma of the head and neck. Am J Surg. 1989;158:388-391.
13. Fisher SR. Cutaneous malignant melanoma of the head and neck. Laryngoscope. 1989;99(8 pt 1):822-836.
14. Andersson AP, Gottlieb J, Drzewiecki KT, et al. Skin melanoma of the head and neck: prognostic factors and recurrence-free survival in 512 patients. Cancer. 1992;69:1153-1156.
15. Ringborg U, Afzelius LE, Lagerlof B, et al. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer. 1993;71:751-758.
16. Garbe C, Buttner P, Bertz J, et al. Primary cutaneous melanoma: prognostic classification of anatomic location. Cancer. 1995;75:2492-2498.
17. Close LG, Goepfert H, Ballantyne AJ. Malignant melanoma of the scalp. Laryngoscope. 1979;89:1189-1196.
18. Essner R, Wong JH, Economou JS, et al. Prognostic significance of melanoma arising in the scalp. Am J Surg. 1988;156:314-317.
19. Stern SJ, Guillamondegui OM. Mucosal melanoma of the head and neck. Head Neck. 1991;13:22-27.
20. Kingdom TT, Kaplan MJ. Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck. 1995;17:184-189.
21. Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002;24:247-257.
22. Medina JE, Ferlito A, Pellitteri PK, et al. Current management of mucosal melanoma of the head and neck. J Surg Oncol. 2003;83:116-122.
23. Yii NW, Eisen T, Nicolson M, et al. Mucosal malignant melanoma of the head and neck: the Marsden experience over half a century. Clin Oncol (R Coll Radiol). 2003;15:199-204.
24. Prasad ML, Busam KJ, Patel SG, et al. Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract. Arch Pathol Lab Med. 2003;127:997-1002.
25. Prasad ML, Patel SG, Huvos AG, et al. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage I (lymph node-negative) tumors. Cancer. 2004;100:1657-1664.
26. Martin JM, Porceddu S, Weih L, et al. Outcomes in sinonasal mucosal melanoma. ANZ J Surg. 2004;74:838-842.
27. Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg. 2003;129:864-868.
28. Temam S, Mamelle G, Marandas P, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer. 2005;103:313-319.
29. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.
30. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer Verlag; 2002:209-217.
31. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-3634.
32. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292:2771-2776.
33. Krown SE, Chapman PB. Defining adequate surgery for primary melanoma. N Engl J Med. 2004;350:823-825.
34. Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg. 2002;137:1101-1105.
35. Ballo MT, Bonnen MD, Garden AS, et al. Adjuvant irradiation for cervical lymph node metastases for melanoma. Cancer. 2003;97:1789-1796.
36. Bonnen MD, Ballo MT, Myers JN, et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer. 2004;100:383-389.
37. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999;230:453-465.
38. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned form the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212-223.
39. Reintgen D, Pendas S, Jakub J, et al. National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. Semin Oncol. 2004;31:363-373.
40. O'Brien CJ, Petersen-Schaefer K, Ruark D, et al. Radical, modified, and selective neck dissection for cutaneous malignant melanoma. Head Neck. 1995;17:232-241.
41. Pathak I, O'Brien CJ, Petersen-Schaefer K, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck. 2001;23.785-790.
42. O'Brien CJ, McNeil EB, McMahon JD, et al. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck. 2001;23:744-748.
43. Lee RJ, Gibbs JF, Proulx GM, et al. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46:467-474.
44. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg. 1986; 73:906-908.
45. Bogle M, Kelly P, Shenaq J, et al. The role of soft tissue reconstruction after melanoma resection in the head and neck. Head Neck. 2001;23:8-15.